ArticleJAMA network open2022

Association of Subcutaneous or Intravenous Administration of Casirivimab and Imdevimab Monoclonal Antibodies With Clinical Outcomes in Adults With COVID-19.

Erin K McCreary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.